Latest News and Press Releases
Want to stay updated on the latest news?
-
ROCKVILLE, Md., Aug. 7, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company") announces the filing of a 510(k) premarket notification with the U.S. Food and Drug Administration...
-
ROCKVILLE, Md., July 29, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company"), announces receipt of a letter from NYSE Amex LLC (the "Exchange") indicating that the Exchange has...
-
ROCKVILLE, Md., May 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) today announced the publication in WOUNDS of a paper entitled "Double impact": Synergism in using Negative Pressure...
-
ROCKVILLE, Md., May 14, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), today announced that on May 13, 2009 it received notice from the NYSE Amex (the "Exchange") notifying the Company it...
-
ROCKVILLE, Md., April 23, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), today announced that it will be exhibiting at the 22nd Annual Symposium on Advanced Wound Care and Wound Healing...
-
ROCKVILLE, Md., April 9, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) announced today that Chief Executive Officer Martin Rosendale discussed the company and his leadership style in an...
-
ROCKVILLE, Md., March 31, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) announced today that Chief Executive Officer Martin Rosendale issued the following letter to shareholders providing a...
-
ROCKVILLE, Md., March 31, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) today reported financial results for the year ended December 31, 2008. On March 31, 2009, the Company filed with...
-
ROCKVILLE, Md., Feb. 5, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Alternext US:GTF) announced today that it has appointed C. Eric Winzer to its Board of Directors; Mr. Winzer will also serve as...
-
ROCKVILLE, Md., Dec. 10, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Alternext US: GTF) announced today that a cost-effectiveness analysis comparing the Company's Platelet Rich Plasma (PRP) gel,...